Global Clinical Trials Activity in the Details

In 2006, four out of ten (41%) active FDA regulated principal investigators were based outside the United States, according to an analysis conducted by the Tufts Center for the Study of Drug Development. Since 2002, the number of U.S.-based clinical investigators filing new Forms FDA 1572 has declined by 5.5% annually. During the same period, the number of active FDA regulated investigators based outside the United States has grown by 15% annually.

View Full Article